Treg cells promote immunosuppression by inhibiting immune response to cancer cells, and the expression of CD4+ CD25+ CD127low Tregs had a positive correlation with TGF-β1 and IL-10 expressions and was closely linked to tumor occurrence and development and immunotherapy reactivity [33, 43]. This evidence concerns the gene TGFB1 and neoplasm.